Grifols SA (GRFS)
7.98
-0.13
(-1.60%)
USD |
NASDAQ |
May 22, 16:00
7.98
0.00 (0.00%)
Pre-Market: 20:00
Grifols Free Cash Flow : 680.05M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals Plc | -8.310M |
| NuCana Plc | -9.929M |
| Amarin Corp. Plc | 25.63M |
| Cellectis SA | -41.80M |
| Akari Therapeutics Plc | -10.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 128.69M |
| Cash from Investing (Quarterly) | -138.05M |
| Cash from Financing (Quarterly) | -152.09M |
| Free Cash Flow Per Share (Quarterly) | 0.0344 |
| Free Cash Flow to Equity (Quarterly) | -847.83M |
| Free Cash Flow to Firm (Quarterly) | 150.54M |
| Free Cash Flow Yield | 12.53% |